CBL — Control Bionics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapMomentum Trap

Annual balance sheet for Control Bionics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

	2022 June 30th	C2023 June 30th	2024 June 30th	2025 June 30th	2026 June 30th
Period Length:	12 M	—	12 M	12 M	12 M
Source:	ARS	Interim Report	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	5.21	0.935	0.981	0.595	2.08
Net Total Accounts Receivable
Net Total Receivables	1.48	1.98	1.45	1.97	1.35
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	8.61	3.87	3.76	3.17	4.18
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.734	0.72	1.22	0.844	0.355
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	13.4	8.7	9.03	8.23	9.05
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1.36	1.47	2.4	2.55	2.72
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1.51	1.55	2.76	2.72	2.73
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	11.9	7.15	6.27	5.51	6.31
Total Liabilities & Shareholders' Equity	13.4	8.7	9.03	8.23	9.05
Total Common Shares Outstanding